222 related articles for article (PubMed ID: 15937818)
61. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
62. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
63. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
64. [Bacteremia in children with tumors or malignant diseases 1991-2000].
Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
[TBL] [Abstract][Full Text] [Related]
65. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
66. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
67. [Immunohistochemistry expression of 3 markers (CEA, UEA-I and Ki-67) in nasal inverted papillomas].
De Gabory L; Deminière C; Stoll D
Rev Laryngol Otol Rhinol (Bord); 2008; 129(3):159-65. PubMed ID: 19694158
[TBL] [Abstract][Full Text] [Related]
68. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
69. Outcomes of primary liver cancer in children: an appraisal of experience.
Pham TH; Iqbal CW; Grams JM; Zarroug AE; Wall JC; Ishitani MB; Nagorney DM; Moir C
J Pediatr Surg; 2007 May; 42(5):834-9. PubMed ID: 17502194
[TBL] [Abstract][Full Text] [Related]
70. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
71. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
72. Benign vascular proliferations--an immunohistochemical and comparative study.
Dyduch G; Okoń K; Mierzyński W
Pol J Pathol; 2004; 55(2):59-64. PubMed ID: 15469208
[TBL] [Abstract][Full Text] [Related]
73. Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas.
Agozzino L; Ferraraccio F; Accardo M; Esposito S; Agozzino M; Cuccurullo L
Ultrastruct Pathol; 2006; 30(3):143-50. PubMed ID: 16825115
[TBL] [Abstract][Full Text] [Related]
74. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
[TBL] [Abstract][Full Text] [Related]
75. [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer].
Raĭkhlin NT; Bukaeva IA; Smirnova EA; Gurevich LE; Delektorskaia VV; Polotskiĭ BE; Laktionov KK; Ardzinba Ms
Arkh Patol; 2008; 70(3):15-8. PubMed ID: 18727426
[TBL] [Abstract][Full Text] [Related]
76. GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma.
Idrees MT; Schlosshauer P; Li G; Burstein DE
Histopathology; 2006 Jul; 49(1):75-81. PubMed ID: 16842248
[TBL] [Abstract][Full Text] [Related]
77. Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas.
Kim BH; Bae YS; Kim SH; Jeong HJ; Hong SW; Yoon SO
APMIS; 2013 Feb; 121(2):105-10. PubMed ID: 23030396
[TBL] [Abstract][Full Text] [Related]
78. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
79. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
[TBL] [Abstract][Full Text] [Related]
80. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
